The epiglottitis treatment market is projected to grow from USD 11.5 billion in 2025 to USD 18.4 billion by 2035, at a CAGR of 4.8%. Broad-spectrum Antibiotic will dominate with a 52.4% market share, while parental will lead the route of administration segment with a 58.7% share.